GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (OTCPK:GLAXF) » Definitions » E10

GSK (GLAXF) E10 : $1.91 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is GSK E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

GSK's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.108. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $1.91 for the trailing ten years ended in Dec. 2023.

During the past 12 months, GSK's average E10 Growth Rate was -0.70% per year. During the past 3 years, the average E10 Growth Rate was 8.60% per year. During the past 5 years, the average E10 Growth Rate was 7.70% per year. During the past 10 years, the average E10 Growth Rate was 1.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of GSK was 12.20% per year. The lowest was -5.40% per year. And the median was 3.35% per year.

As of today (2024-04-28), GSK's current stock price is $19.852. GSK's E10 for the quarter that ended in Dec. 2023 was $1.91. GSK's Shiller PE Ratio of today is 10.39.

During the past 13 years, the highest Shiller PE Ratio of GSK was 17.38. The lowest was 8.44. And the median was 12.94.


GSK E10 Historical Data

The historical data trend for GSK's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK E10 Chart

GSK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.43 1.56 1.62 1.84 1.91

GSK Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.84 1.94 2.01 1.91 1.91

Competitive Comparison of GSK's E10

For the Drug Manufacturers - General subindustry, GSK's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where GSK's Shiller PE Ratio falls into.



GSK E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, GSK's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.108/130.0000*130.0000
=0.108

Current CPI (Dec. 2023) = 130.0000.

GSK Quarterly Data

per share eps CPI Adj_EPS
201403 0.284 99.300 0.372
201406 0.283 99.800 0.369
201409 0.167 100.000 0.217
201412 0.417 99.900 0.543
201503 3.109 99.600 4.058
201506 0.060 100.100 0.078
201509 0.211 100.200 0.274
201512 -0.137 100.400 -0.177
201603 0.103 100.400 0.133
201606 -0.160 101.000 -0.206
201609 0.271 101.500 0.347
201612 0.081 102.200 0.103
201703 0.329 102.700 0.416
201706 -0.059 103.500 -0.074
201709 0.410 104.300 0.511
201712 -0.188 105.000 -0.233
201803 0.194 105.100 0.240
201806 0.148 105.900 0.182
201809 0.466 106.600 0.568
201812 0.386 107.100 0.469
201903 0.275 107.000 0.334
201906 0.306 107.900 0.369
201909 0.480 108.400 0.576
201912 0.424 108.500 0.508
202003 0.483 108.600 0.578
202006 0.704 108.800 0.841
202009 0.400 109.200 0.476
202012 0.225 109.400 0.267
202103 0.369 109.700 0.437
202106 0.484 111.400 0.565
202109 0.396 112.400 0.458
202112 0.244 114.700 0.277
202203 0.585 116.500 0.653
202206 0.203 120.500 0.219
202209 2.998 122.300 3.187
202212 0.445 125.300 0.462
202303 0.443 126.800 0.454
202306 0.401 129.400 0.403
202309 0.441 130.100 0.441
202312 0.108 130.000 0.108

Add all the adjusted EPS together and divide 10 will get our e10.


GSK  (OTCPK:GLAXF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

GSK's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=19.852/1.91
=10.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of GSK was 17.38. The lowest was 8.44. And the median was 12.94.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


GSK E10 Related Terms

Thank you for viewing the detailed overview of GSK's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK (GLAXF) Business Description

Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.